Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1992-12-11
1995-01-24
Hill, Jr., Robert J.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
4352401, 4352402, 4351721, 4351723, 4353201, 435 30, 435 34, C12N 500, C12N 1500, C12Q 124, C12Q 104
Patent
active
053842430
ABSTRACT:
The present invention relates, in general, to a method of screening agents. In particular, the present invention relates to a method of testing the cancer preventing activity of a drug and of testing an agent for its ability to prevent cell transformation.
REFERENCES:
patent: 4937232 (1990-06-01), Bell et al.
J. Downward, et al., "Close Similarity of Epidermal Growth Factor Receptor and v-erb-B Oncogene Protein Sequences", Nature, vol. 307, Feb. 9, 1984, pp. 521-527.
Fernando Leal, et al., "Evidence That the v-sis Gene Product Transforms by Interaction with the Receptor for Platelet-Derived Growth Factor", Science, vol. 230, Oct. 18. 1985, pp. 327-330.
Tai Kubo, et al., "Cloning, Sequencing and Expression of Complementary DNA Encoding the Muscarinic Acetylcholine Receptor", Nature, Oct. 2, 1986, pp. 411-416.
Dallan Young, et al., "Isolation and Characterization of a New Cellular Oncogene Encoding a Protein with Multiple Potential Transmembrane Domains", Cell, vol. 45, Jun. 6, 1986, pp. 711-719.
Yarden, et al., "Structure of the Receptor for Platelet-Derived Growth Factor Helps Define a Family of Closely Related Growth Factor Receptors", Nature, vol. 323, Sep. 18, 1986, pp. 226-232.
Thierry J. Velu, et al., "Epidermal Growth Factor-Dependent Transformation by a Human EGF Receptor Proto-Oncogene", Science, vol. 238, May 29, 1987, pp. 1408-1410.
Pier Paolo Di Fiore, et al., "Overexpression of the Human EGF Receptor Confers an EGF-Dependent Transformed Phenotype to NIH 3T3 Cells", Cell, vol. 51, Dec. 24, 1987, pp. 1063-1070.
Ernest G. Peralta, et al., "Distinct Primary Structures, Ligand-Binding Properties and Tissue-Specific Expression of Four Human Muscarinic Acetylcholine Receptors", The EMBO Journal vol. 6, Nov. 13, 1987, pp. 3923-3929.
T. I. Bonner, et al., "Identification of a Family of Muscarinic Acetylcholine Receptor Genes", Science, vol. 237, Jul. 31, 1987, pp. 527-532.
Bruce R. Conklin, et al., "Stimulation of Arachidonic Acid Release and Inhibition of Mitogenesis by Cloned Genes for Muscarinic Receptor Subtypes Stably Expresses in A9 L Cells", Proc. Natl. Acad. Sci., vol. 85, Nov. 1988, pp. 8698-8702.
Toshimitus matsui, et al., "Isolation of a Novel Receptor CDNA Establishes the Existance of Two PDGF Receptor Genes", Science, vol. 243, Feb. 10, 1989, pp. 800-804.
S. V. Penelope Jones, et al., "Cloned Muscarinic Receptor Subtypes Expressed in A9 Cells Differ in Their Coupling to Electrical Responses", Molecular Pharmacology, vol. 34, Jul. 11, 1988, pp. 421-426.
Tom I. Bonner, "m5 Muscarinic Acetylcholine Receptor Genes" Neuron, vol. 1, 1988, pp. 403-410.
Ernest G. Peralta, et al. "Differential Regulation of PI Hydrolysis and Adenylyl Cyclase by Muscarinic Receptor Subtypes", Nature, vol. 334, Aug. 4, 1988, pp. 434-436.
Fukuda, et al., "Selective Coupling with K+ Currents of Muscarinic Acetylcholine Receptor Subtypes in NG108-15 Cells", Nature, vol. 335, Sep. 22, 1988, pp. 355-358.
David Julius, et al., "Ectopic Expression of the Serotonin lc Receptor and the Triggering of Malignant Transformation", Science, vol. 244, Jun. 2, 1989, pp. 1057-1062.
Avi Ashkensazi, et al., "Acetylcholine Analogue Stimulates DNA Synthesis in Brain-Derived Cells Via Specific Muscarinic Receptor Subtypes", Nature, vol. 340, Jul. 31, 1989, pp. 146-150.
Angela K. Thompson, et al. "Relationship Between Agonist-Induced Muscarinic Receptor Loss and Desensitization of Stimulated Phophoinositide Turnover in Two Neuroblastomas: Methodological Considerations", The Journal of Pharmacology and Experimental Therapeutics, vol. 252, Oct. 30, 1990, pp. 744-752.
J. Trejo et al., "Muscarinic Receptor Stimulation Induces C-FOS Through a PKC Dependent Mechanism in 1321N1 But Not in NG108-15 Cells", The FASEB Journal, vol. 4, No. 7, Apr. 1990.
J. Silvio Gutkind, et al., "Muscarinic Acetylcholine Receptor Subtypes as Agonist-Dependent Oncogenes", Proc. Natl. Acad. Sci. USA, vol. 88, Jun. 1991, pp. 4703-4707.
Trejo et al. (Jun. 4-7, 1990), The FASEB Journal, vol. 4, No. 7: A2097, #2386.
Thompson et al. (Feb., 1990), The Journal of Pharmacology and Experimental Therapeutics, vol. 252, #2, pp. 744-752.
Gutkind J. Silvio
Robbins Keith C.
Hill Jr. Robert J.
The United States of America as represented by the Department of
Wang Gian P.
LandOfFree
Method for screening an agent for its ability to prevent cell tr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for screening an agent for its ability to prevent cell tr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for screening an agent for its ability to prevent cell tr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1468212